These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 16241947)

  • 41. Molecular modeling predicts structural changes in the A subunit of factor XIII caused by two novel mutations identified in a neonate with severe congenital factor XIII deficiency.
    Souri M; Yee VC; Fujii N; Ichinose A
    Thromb Res; 2012 Sep; 130(3):506-10. PubMed ID: 22633530
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The role of β-barrels 1 and 2 in the enzymatic activity of factor XIII A-subunit.
    Hethershaw EL; Adamson PJ; Smith KA; Goldsberry WN; Pease RJ; Radford SE; Grant PJ; Ariëns RAS; Maurer MC; Philippou H
    J Thromb Haemost; 2018 Jul; 16(7):1391-1401. PubMed ID: 29675848
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A common mutation in the gene for coagulation factor XIII-A (VAL34Leu): a risk factor for primary intracerebral hemorrhage is protective against atherothrombotic diseases.
    Gemmati D; Serino ML; Ongaro A; Tognazzo S; Moratelli S; Resca R; Moretti M; Scapoli GL
    Am J Hematol; 2001 Jul; 67(3):183-8. PubMed ID: 11391716
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Influence of the 4600A/G and 4678G/C polymorphisms in the endothelial protein C receptor (EPCR) gene on the risk of venous thromboembolism in carriers of factor V Leiden.
    Medina P; Navarro S; Estellés A; Vayá A; Bertina RM; España F
    Thromb Haemost; 2005 Aug; 94(2):389-94. PubMed ID: 16113830
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Association of genetic variants of hemostatic genes with myocardial infarction in Egyptian patients.
    El-Fattah AAA; Sadik NAH; Sedrak H; Battah A; Nabil M
    Gene; 2018 Jan; 641():212-219. PubMed ID: 29054763
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Factor XIII-A subunit Val34Leu polymorphism is associated with the risk of thrombosis in patients with antiphospholipid antibodies and high fibrinogen levels.
    de la Red G; Tàssies D; Espinosa G; Monteagudo J; Bové A; Plaza J; Cervera R; Reverter JC
    Thromb Haemost; 2009 Feb; 101(2):312-6. PubMed ID: 19190815
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Factor XIII deficiency: complete phenotypic characterization of two cases with novel causative mutations.
    Katona É; Muszbek L; Devreese K; Kovács KB; Bereczky Z; Jonkers M; Shemirani AH; Mondelaers V; Ermens AA
    Haemophilia; 2014 Jan; 20(1):114-20. PubMed ID: 24118344
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Association of Coagulation Factors VIII/XI/XIII Polymorphisms With Coagulation Factor Activities and Deep Vein Thrombosis After Artificial Joints Replacement.
    Su W; Lv M; Xu X; Li B; Liu HY; Ning B; Li Y
    Am J Ther; 2016; 23(6):e1547-e1553. PubMed ID: 26934731
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Factor XIII and venous thromboembolism.
    Bereczky Z; Muszbek L
    Semin Thromb Hemost; 2011 Apr; 37(3):305-14. PubMed ID: 21455864
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prevalence of the Factor V Leiden Mutation Arg534Gln in Western Region of Saudi Arabia: Functional Alteration and Association Study With Different Populations.
    Athar M; Abduljaleel Z; Ghita IS; Albagenny AA; Halawani SH; Alkazmi MM; Elbjeirami WM; Alquthami K; Alkhuzae MM; Ragab FM; Al-Allaf FA
    Clin Appl Thromb Hemost; 2021; 27():1076029620978532. PubMed ID: 33448877
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A FV multiallelic marker detects genetic components of APC resistance contributing to venous thromboembolism in FV Leiden carriers.
    Mingozzi F; Legnani C; Lunghi B; Scanavini D; Castoldi E; Palareti G; Marchetti G; Bernardi F
    Thromb Haemost; 2003 Jun; 89(6):983-9. PubMed ID: 12783110
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The association between factor XIII Val34Leu polymorphism and early myocardial infarction.
    Hancer VS; Diz-Kucukkaya R; Bilge AK; Ozben B; Oncul A; Ergen G; Nalcaci M
    Circ J; 2006 Mar; 70(3):239-42. PubMed ID: 16501286
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Identification of a new mutation (Gly420Ser), distal to the active site, that leads to factor XIII deficiency.
    Kangsadalampai S; Yenchitsomanus P; Chelvanayagam G; Sawasdee N; Laosombat V; Board P
    Eur J Haematol; 2000 Oct; 65(4):279-84. PubMed ID: 11073170
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Sushi domains in the B subunit of factor XIII responsible for oligomer assembly.
    Souri M; Kaetsu H; Ichinose A
    Biochemistry; 2008 Aug; 47(33):8656-64. PubMed ID: 18652485
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The protective effect of the factor XIII Val34Leu mutation on the risk of deep venous thrombosis is dependent on the fibrinogen level.
    Vossen CY; Rosendaal FR
    J Thromb Haemost; 2005 May; 3(5):1102-3. PubMed ID: 15869621
    [No Abstract]   [Full Text] [Related]  

  • 56. Factor XIIIV34L is not an additional genetic risk for venous thrombosis in factor V Leiden carriers.
    Morange PE; Henry M; Brunet D; Aillaud MF; Juhan-Vague I
    Blood; 2001 Mar; 97(6):1894-5. PubMed ID: 11263439
    [No Abstract]   [Full Text] [Related]  

  • 57. Factor XIII Val34Leu polymorphism and gamma-chain cross-linking at the site of microvascular injury in healthy and coumadin-treated subjects.
    Undas A; Brzezinska-Kolarz B; Brummel-Ziedins K; Musial J; Szczeklik A; Mann KG
    J Thromb Haemost; 2005 Sep; 3(9):2015-21. PubMed ID: 16102108
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Role of factor XIII Val34Leu polymorphism in retinal artery occlusion.
    Weger M; Renner W; Stanger O; Schmut O; Deutschmann H; Wascher TC; Haas A
    Stroke; 2001 Dec; 32(12):2759-61. PubMed ID: 11739969
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Single and combined prothrombotic factors in patients with idiopathic venous thromboembolism: prevalence and risk assessment.
    Salomon O; Steinberg DM; Zivelin A; Gitel S; Dardik R; Rosenberg N; Berliner S; Inbal A; Many A; Lubetsky A; Varon D; Martinowitz U; Seligsohn U
    Arterioscler Thromb Vasc Biol; 1999 Mar; 19(3):511-8. PubMed ID: 10073951
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Lack of association between the C677T mutation in the 5,10-methylenetetrahydrofolate reductase gene and venous thromboembolism in Northwestern Greece.
    Zalavras ChG; Giotopoulou S; Dokou E; Mitsis M; Ioannou HV; Tzolou A; Kolaitis N; Vartholomatos G
    Int Angiol; 2002 Sep; 21(3):268-71. PubMed ID: 12384649
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.